132 related articles for article (PubMed ID: 22434029)
1. Therapeutic blockade of interleukin-6 in chronic inflammatory disease.
Yamamoto K; Rose-John S
Clin Pharmacol Ther; 2012 Apr; 91(4):574-6. PubMed ID: 22434029
[No Abstract] [Full Text] [Related]
2. Induction of severe systemic lupus erythematosus by TNF blockade and response to anti-IL-6 strategy.
Adler S; Kolev M; Varisco PA; Tham M; von Gunten M; Tappeiner C; Villiger PM
J Allergy Clin Immunol; 2013 Apr; 131(4):1235-7, 1237.e1. PubMed ID: 23154083
[No Abstract] [Full Text] [Related]
3. Immunotherapeutic implication of IL-6 blockade.
Tanaka T; Kishimoto T
Immunotherapy; 2012 Jan; 4(1):87-105. PubMed ID: 22150003
[TBL] [Abstract][Full Text] [Related]
4. From RESCUE to ZEUS: will interleukin-6 inhibition with ziltivekimab prove effective for cardiovascular event reduction?
Ridker PM
Cardiovasc Res; 2021 Sep; 117(11):e138-e140. PubMed ID: 34352102
[No Abstract] [Full Text] [Related]
5. Inflammatory cytokines at the summits of pathological signal cascades in brain diseases.
Steinman L
Sci Signal; 2013 Jan; 6(258):pe3. PubMed ID: 23322904
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6: Biology, signaling and strategies of blockade.
Schaper F; Rose-John S
Cytokine Growth Factor Rev; 2015 Oct; 26(5):475-87. PubMed ID: 26189695
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 6 blockade: tocilizumab in psoriatic arthritis.
Atzeni F; Ventura D; Batticciotto A; Boccassini L; Sarzi-Puttini P
J Rheumatol Suppl; 2012 Jul; 89():97-9. PubMed ID: 22751605
[TBL] [Abstract][Full Text] [Related]
8. The biology behind interleukin-6 targeted interventions.
Liu X; Jones GW; Choy EH; Jones SA
Curr Opin Rheumatol; 2016 Mar; 28(2):152-60. PubMed ID: 26751841
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic uses of anti-interleukin-6 receptor antibody.
Kang S; Tanaka T; Kishimoto T
Int Immunol; 2015 Jan; 27(1):21-9. PubMed ID: 25142313
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 is a candidate molecule that transmits inflammatory information to the CNS.
Oka Y; Ibuki T; Matsumura K; Namba M; Yamazaki Y; Poole S; Tanaka Y; Kobayashi S
Neuroscience; 2007 Mar; 145(2):530-8. PubMed ID: 17303338
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 6 blockade for hyperimmunoglobulin D and periodic fever syndrome.
Shendi HM; Devlin LA; Edgar JD
J Clin Rheumatol; 2014 Mar; 20(2):103-5. PubMed ID: 24561416
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 and rheumatic diseases.
Lipsky PE
Arthritis Res Ther; 2006; 8 Suppl 2(Suppl 2):S4. PubMed ID: 16899108
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 as a key player in systemic inflammation and joint destruction.
Fonseca JE; Santos MJ; Canhão H; Choy E
Autoimmun Rev; 2009 Jun; 8(7):538-42. PubMed ID: 19189867
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of IL-6 for the treatment of inflammatory diseases.
Nishimoto N; Kishimoto T
Curr Opin Pharmacol; 2004 Aug; 4(4):386-91. PubMed ID: 15251133
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 6 blockade as steroid-sparing treatment for 2 patients with giant cell arteritis.
Sciascia S; Rossi D; Roccatello D
J Rheumatol; 2011 Sep; 38(9):2080-1. PubMed ID: 21885526
[No Abstract] [Full Text] [Related]
16. New therapeutic options in rheumatoid arthritis: a focus on interleukin-6 blockade.
Furfaro N
J Infus Nurs; 2011; 34(2):107-15. PubMed ID: 21399456
[TBL] [Abstract][Full Text] [Related]
17. Gene of the month: Interleukin 6 (IL-6).
Ataie-Kachoie P; Pourgholami MH; Richardson DR; Morris DL
J Clin Pathol; 2014 Nov; 67(11):932-7. PubMed ID: 25031389
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of anti-cytokines and anti-RANKL antibody for treatment of RA and osteoporosis].
Okada Y; Nawata M; Tanaka Y
Clin Calcium; 2007 Nov; 17(11):1762-8. PubMed ID: 17982198
[TBL] [Abstract][Full Text] [Related]
19. [Staffan Normark on new discoveries concerning "innate immunity". The first line protection starts chronic inflammatory processes].
Wilhelmson B
Lakartidningen; 1999 Dec; 96(48):5346-50. PubMed ID: 10612983
[No Abstract] [Full Text] [Related]
20. A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy.
Tanaka T; Narazaki M; Ogata A; Kishimoto T
Semin Immunol; 2014 Feb; 26(1):88-96. PubMed ID: 24594001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
